{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T20:32:08Z","timestamp":1768422728912,"version":"3.49.0"},"reference-count":16,"publisher":"SAABRON PRESS","issue":"2-3","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Hematol Int"],"DOI":"10.1007\/s44228-023-00035-9","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T03:29:13Z","timestamp":1682047753000},"page":"107-111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical and Cytogenetic Characterization, and Outcome of Chronic Lymphocytic Leukemia Patients in a Single Tertiary Center in Saudi Arabia"],"prefix":"10.46989","volume":"5","author":[{"given":"Areej","family":"Al Mugairi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekremah","family":"Alzarea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulaziz","family":"Almosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feisal","family":"Alsomali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulmajeed","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawaz","family":"Alhamied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faris","family":"Albogami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubna","family":"Al Zajdali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"AlBalwi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad","family":"Masaudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Al Hijazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moussab","family":"Damlaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Alaskar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"26435","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"key":"35_CR1","first-page":"CD012022","volume":"7","author":"N Kreuzberger","year":"2020","unstructured":"Kreuzberger N, et al. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis. Cochrane Database Syst Rev. 2020;7:CD012022.","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"35_CR2","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/ajh.26367","volume":"96","author":"M Hallek","year":"2021","unstructured":"Hallek M, Al-Sawaf O. Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures. Am J Hematol. 2021;96(12):1679\u2013705.","journal-title":"Am J Hematol"},{"key":"35_CR3","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1186\/s12885-019-5897-5","volume":"19","author":"A Bawazir","year":"2019","unstructured":"Bawazir A, Al-Zamel N, Amen AEA. The burden of leukemia in the Kingdom of Saudi Arabia: 15 years period (1999\u20132013). BMC Cancer. 2019;19:703.","journal-title":"BMC Cancer"},{"issue":"3","key":"35_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.htct.2019.07.006","volume":"42","author":"I Zalcberg","year":"2020","unstructured":"Zalcberg I, et al. Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL\u2014ERIC recommendations. Hematol Transfus Cell Ther. 2020;42(3):269\u201374.","journal-title":"Hematol Transfus Cell Ther"},{"issue":"23","key":"35_CR5","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1182\/blood.2020010536","volume":"138","author":"AS Kittai","year":"2021","unstructured":"Kittai AS, et al. The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib. Blood. 2021;138(23):2372\u201382.","journal-title":"Blood"},{"issue":"1","key":"35_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.annonc.2020.09.019","volume":"32","author":"B Eichhorst","year":"2021","unstructured":"Eichhorst B, et al. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021;32(1):23\u201333.","journal-title":"Ann Oncol"},{"issue":"25","key":"35_CR7","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","volume":"131","author":"M Hallek","year":"2018","unstructured":"Hallek M, et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018;131(25):2745\u201360.","journal-title":"Blood"},{"issue":"3","key":"35_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/joah.joah_27_18","volume":"9","author":"RM Wedian","year":"2018","unstructured":"Wedian RM, Salem KH, Emad GE. B-Cell chronic lymphocytic leukemia fluorescence in situ hybridization panel findings at Tertiary Care Hospital in Saudi Arabia. J Appl Hematol. 2018;9(3):81\u20134.","journal-title":"J Appl Hematol"},{"issue":"2","key":"35_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.clml.2017.11.010","volume":"18","author":"A Mato","year":"2018","unstructured":"Mato A, et al. Prognostic testing patterns and outcomes of chronic lymphocytic leukemia patients stratified by fluorescence in situ hybridization\/cytogenetics: a real-world clinical experience in the connect CLL registry. Clin Lymphoma Myeloma Leuk. 2018;18(2):114-124.e2.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"35_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.leukres.2017.01.023","volume":"55","author":"SJ Huang","year":"2017","unstructured":"Huang SJ, et al. Characterization of treatment and outcomes in a population-based cohort of patients with chronic lymphocytic leukemia referred for cytogenetic testing in British Columbia, Canada. Leuk Res. 2017;55:79\u201390.","journal-title":"Leuk Res"},{"issue":"7","key":"35_CR11","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1182\/bloodadvances.2019001145","volume":"4","author":"A Mato","year":"2020","unstructured":"Mato A, et al. The Connect CLL Registry: final analysis of 1494 patients with chronic lymphocytic leukemia across 199 US sites. Blood Adv. 2020;4(7):1407\u201318.","journal-title":"Blood Adv"},{"issue":"1","key":"35_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/bjh.13933","volume":"173","author":"DL Van Dyke","year":"2016","unstructured":"Van Dyke DL, et al. The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience. Br J Haematol. 2016;173(1):105\u201313.","journal-title":"Br J Haematol"},{"issue":"10","key":"35_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101176","volume":"14","author":"YX Zou","year":"2021","unstructured":"Zou YX, et al. Low prevalence and independent prognostic role of del(11q) in Chinese patients with chronic lymphocytic leukemia. Transl Oncol. 2021;14(10): 101176.","journal-title":"Transl Oncol"},{"issue":"3","key":"35_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/ajh.23618","volume":"89","author":"P Baliakas","year":"2014","unstructured":"Baliakas P, et al. Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data. Am J Hematol. 2014;89(3):249\u201355.","journal-title":"Am J Hematol"},{"key":"35_CR15","volume-title":"SEER cancer statistics review 1975\u20132016","author":"N Howlader","year":"2019","unstructured":"Howlader N, et al. SEER cancer statistics review 1975\u20132016. Bethesda: National Cancer Institute; 2019."},{"issue":"8","key":"35_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14258","volume":"75","author":"BS Ko","year":"2021","unstructured":"Ko BS, et al. Epidemiology, treatment patterns and survival of chronic lymphocytic leukaemia\/small lymphocytic lymphoma (CLL\/SLL) in Taiwan, 2006\u20132015. Int J Clin Pract. 2021;75(8): e14258.","journal-title":"Int J Clin Pract"}],"container-title":["Clinical Hematology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44228-023-00035-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44228-023-00035-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44228-023-00035-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T09:21:49Z","timestamp":1694424109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44228-023-00035-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":16,"journal-issue":{"issue":"2-3","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["35"],"URL":"https:\/\/doi.org\/10.1007\/s44228-023-00035-9","relation":{},"ISSN":["2590-0048"],"issn-type":[{"value":"2590-0048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"assertion":[{"value":"15 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author reports no relevant financial or non-financial interest to disclose. The authors did not receive support from any organization for the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the institutional review Board (IRB) of King Abdullah International Medical research center (KAIMRC) with IRB number (SP20-253-R) in July, 2020. The requirement for informed consent was waived by the ethic committee for retrospective data collection.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}